Actos Lawsuit Attorneys
The diabetes drug Actos (pioglitazone) has been linked to an increased risk of bladder cancer in a number of international studies. Actos, approved by the FDA in 1999 to treat Type 2 diabetes, works to help reduce insulin resistance and has been a popular alternative to Avandia, which has been linked to heart disease, stroke, and other health threats. While no causal relation between Actos and bladder cancer has been determined, a number of scientific studies have noted a disproportionately high rate of bladder cancer among Actos users.
Our Actos bladder cancer lawsuit attorneys are currently reviewing dangerous medication claims against Takeda Pharmaceuticals, the maker of Actos. In many cases, victims of Actos bladder cancer claim that they were not adequately warned of the elevated risk of cancer associated with Actos. If you have developed bladder cancer after taking Actos, you may be entitled to substantial compensation in a pharmaceutical product liability Actos bladder cancer lawsuit.
Call our Actos bladder cancer lawsuit attorneys at 1-888-554-2889.
A free, no-obligation Actos lawsuit case evaluation
No fee unless we win your case
Helping Actos side effect victims Nationwide
The Link Between Actos and Bladder Cancer
While Actos is still currently prescribed in the United States, an Actos recall has been issued in France as a result of reports and scientific data pointing to a link between Actos and bladder cancer. Campetact, a related drug sold as ActoplusMet in the United States, has also been recalled in France. In addition to this, a number of countries in Europe have suspended sales of Actos pending further investigation.
In September 2010, the FDA launched an investigation into reports of an increased instance of bladder cancer in people who take Actos. In this investigation, the FDA cited data from an ongoing study by Takeda Pharmaceuticals that claims that the risk of bladder cancer is heightened the longer a person uses Actos. As this study is ongoing, the FDA has yet to release a conclusion to this investigation.
In June 2011, the FDA ordered a revision to the warning label on Actos to inform Actos users that there is an increased risk of bladder cancer linked to this potentially dangerous medication. Similar drugs to Actos, including Actoplus Met, ActoplusMet RX, and Duetact, will also carry this Actos bladder cancer warning.
Actos Bladder Cancer Lawsuits
Actos sales topped $3.4 billion in 2010, and Actos is Takeda Pharmaceutical’s best-selling drug. A number of Actos patients who have been diagnosed with bladder cancer have opted to file an Actos bladder cancer lawsuit in pursuit of just compensation for medical bills and other damages. If you believe you have an Actos bladder cancer lawsuit claim, it is in your best interests to contact a product liability lawyer soon, before a statute of limitations expires and prevents you from filing an Actos lawsuit.
Contact an Actos Bladder Cancer Lawsuit Attorney
The Actos bladder cancer lawsuit attorneys at our firm have years of experience in handling dangerous medication and pharmaceutical product liability lawsuits. If you believe your bladder cancer is linked to Actos, you may be able to file an Actos bladder cancer lawsuit. Contact us today for a free and confidential consultation and an ethical discussion of your legal rights.